-
/riggs-institute/diabetes-complications-and-metabolism/wendong-huang-lab · A Ph.D. or M.D. degree in broad biomedical sciences. · Proficiency in biochemical techniques, molecular biology
-
groundbreaking biomedical research in cancer genomics and biology. Our goal is to do the best science, while training to be the next generation of scientific leaders. The selected candidate will have the
-
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope , where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a...
-
. Your qualifications should include: A doctorate degree and/or relevant background in immunology, neuroscience, biology, or pharmacology. Immunology expertise will take priority. Training in flow
-
research please visit here . As a successful candidate, you will: · Devise, plan, and contribute original ideas to basic science and translational projects focused on 1) immune response to radiation
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope , where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a...
-
receive excellent training in publishing high-quality papers. The following are representative publications: Nature Immunology (PMID: 28846085); Nature Communications (PMID: 30451821), Science advances
-
of Molecular Diagnostics and Experimental Therapeutics, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment
-
of developing novel strategies to improve CAR T cell therapies and thymic function, spanning basic science to clinical trials. For more information about Dr. van den Brink’s research, please visit here . Lab's